Blue Cloud Softech Solutions Limited (BSE: 539607), a provider of AI-enabled enterprise and cybersecurity solutions, has announced the international rollout of its healthcare technology ecosystem—BluBio, BluHealth, and Bioster—across Commonwealth nations. The expansion extends the company’s footprint into regions across Africa, Asia, the Caribbean, and the Pacific, supporting broader access to digital healthcare infrastructure.
At the centre of this global initiative is BluHealth, the company’s integrated digital health platform. BluHealth brings together non-invasive AI screening through facial-scan technology, IoT-powered BluHealth Scanners for real-time diagnostics, BluClinics management systems, and a full-scale Hospital Information Management System (HIMS). Designed for both urban and rural settings, the platform aims to facilitate accessible, connected, and cost-efficient healthcare delivery.
Blue Cloud Softech’s solutions have received endorsements from the Commonwealth Medical Association (CMA) and the Indian Medical Association (IMA). The recognition from these bodies—which jointly represent more than 1.5 million healthcare professionals—marks an important validation of the company’s technology in clinical environments.
The Commonwealth represents one of the world’s most diverse healthcare markets, comprising 56 countries with a combined population of more than 2.5 billion people. Its mix of developed, emerging, and frontier economies offers significant scope for digital transformation, particularly in preventive care, diagnostics, and healthcare management systems.
